These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 17279204

  • 1. Care pathways in early rheumatoid arthritis.
    Bernatsky S, Feldman D, Shrier I, Toupin K, Haggerty J, Tousignant P, Zummer M.
    Can Fam Physician; 2006 Nov; 52(11):1444-5. PubMed ID: 17279204
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey.
    Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS.
    Ann Rheum Dis; 2004 Oct; 63(10):1269-75. PubMed ID: 15361385
    [Abstract] [Full Text] [Related]

  • 4. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV, Arce-Salinas CA, Guzmán-Vázquez S, Cardiel-Ríos MH.
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [Abstract] [Full Text] [Related]

  • 5. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA, Choi M, Ferrari R, Lyddell C, Russell AS.
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [Abstract] [Full Text] [Related]

  • 6. Management of the early and late presentations of rheumatoid arthritis: a survey of Ontario primary care physicians.
    Glazier RH, Dalby DM, Badley EM, Hawker GA, Bell MJ, Buchbinder R, Lineker SC.
    CMAJ; 1996 Sep 15; 155(6):679-87. PubMed ID: 8823213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
    Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X, Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group, Club Rhumatismes et Inflammation, French Society of Rheumatology.
    Arthritis Rheum; 2009 Apr 15; 61(4):425-34. PubMed ID: 19333993
    [Abstract] [Full Text] [Related]

  • 10. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.
    Clin Ther; 2009 Aug 15; 31(8):1737-46. PubMed ID: 19808132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gaps in care for rheumatoid arthritis: a population study.
    Lacaille D, Anis AH, Guh DP, Esdaile JM.
    Arthritis Rheum; 2005 Apr 15; 53(2):241-8. PubMed ID: 15818655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
    Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A.
    J Rheumatol; 2009 Aug 15; 36(8):1611-7. PubMed ID: 19369454
    [Abstract] [Full Text] [Related]

  • 17. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain.
    Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E, emAR Study Group.
    Scand J Rheumatol; 2008 Aug 15; 37(6):419-26. PubMed ID: 18609260
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study.
    Andrianakos A, Trontzas P, Christoyannis F, Kaskani E, Nikolia Z, Tavaniotou E, Georgountzos A, Krachtis P, ESORDIG Study Group.
    Rheumatology (Oxford); 2006 Dec 15; 45(12):1549-54. PubMed ID: 16690763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.